Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | il y a 503
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | il y a 703
Canadian Market Likely To Open With Negative Gap

Canadian Market Likely To Open With Negative Gap

Lower Canadian and U.S. futures amid concerns about tech earnings following the emergence of China's startup DeepSeek's AI model, and worries about U.S. President Donald Trump's policies and tariff threats point to a gap down opening for stocks on Bay Street on Monday.
RTTNews | il y a 9h 25min
Dollar Drops Amidst Softer Tariff Tone, Rate Cut Calls

Dollar Drops Amidst Softer Tariff Tone, Rate Cut Calls

The U.S. Dollar tumbled against major currencies during the week ended January 24 amidst a perceived softening in the U.S. administration's tone on trade tariffs and President Trump's call to global central banks to lower interest rates. Weak economic data updates from the U.S. also aided the Dollar's decline.
RTTNews | il y a 10h 26min
FTSE Modestly Lower; Miners Lose Ground

FTSE Modestly Lower; Miners Lose Ground

U.K. stocks are slightly down Monday morning, due largely to weakness in the mining sector after data showed a contraction in the manufacturing sector in the world's second largest economy.
RTTNews | il y a 10h 43min
CAC 40 Slips As DeepSeek Triggers Tech Sell-off

CAC 40 Slips As DeepSeek Triggers Tech Sell-off

French stocks are down in negative territory Monday morning, snapping a long 9-day winning streak, amid a sell-off in technology stocks due to concerns about the impact of Chinese startup DeepSeek's powerful and cost-efficient AI model on the sector.
RTTNews | il y a 11h 8min
German Business Confidence Improves In January

German Business Confidence Improves In January

German business confidence improved slightly in January on more positive assessment about the current situation but the overall low level continues to signal that the economy remains on weak footing. The ifo business climate index rose more-than-expected to 85.1 in January from 84.7 in the previous month, survey results from the ifo Institute showed on Monday. The reading was seen at 84.9.
RTTNews | il y a 11h 14min